with anti-neuromuscular block drugs: can antagonize the effect of the anti-neuromuscular block drugs on the skeletal muscle (so need to adjust the dose of the drugs for anti-muscle weakness. Combined with ethyl sulfide isoniazid: may increase the side effects. Combined with methoxyflurane or polymyxin injection: may increase renal toxicity or neuromuscular blockade effect. Combined with opioid: The effect of central respiratory inhibition may increase, lead to prolonged respiratory inhibition or respiratory paralysis (apnea). History Capreomycin, an antiphlogistic antibiotic which was produced in the United States in 1960, and be applied in clinic in 1968. In 1979, capreomycin was used in the area of antituberculosis by inhibiting the growth of mycobacterium tuberculosis. References External links Wikipedia medicine articles ready to translate Anti-tuberculosis drugs Polypeptide antibiotics